Itci stock analysis

ITCI - Intra-Cellular Ther Stock Technical Analysis ... Technical Analysis Summary for Intra-Cellular Ther with Moving Average, Stochastics, MACD, RSI, Average Volume.

Use the Advanced Stock Chart's date range selection to toggle between short term and long term stock price charts for ITCI, from one-day to 3-year. On the top chart, you'll see a display of ITCI's stock price, and below, use the Technical Analysis selection to change companion data for the chart. ITCI Stock Price and Chart — NASDAQ:ITCI — TradingView — UK TradingView UK. View live INTRA-CELLULAR THERAPIES INC chart to track its stock's price action. Find market predictions, ITCI financials and market news. Intra-Cellular... (ITCI) Stock Quote | Price Chart ... View a financial market summary for ITCI including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ITCI (Intra-Cellular Therapies Inc.) stock.

Apr 02, 2020 · Intra-Cellular Therapies, Inc. (ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, today announced the grant to four new employees of inducement stock options to purchase an aggregate of 6,688 shares of its common stock and restricted stock units for an

NewsSee all news. 02 April 2020 Intra-Cellular Therapies Initiates Promotional Activities for CAPLYTA™ (lumateperone) for the Treatment of Schizophrenia in Adults. NEW YORK, April 02, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) NASDAQ:ITCI Intra-Cellular Therapies Inc. Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders. Intra-Cellular Therapies (NasdaqGS:ITCI) - Share price ... Intra-Cellular Therapies, Inc., a biopharmaceutical company, engages in developing novel drugs for the treatment of neuropsychiatric and neurodegenerative disorders. The company is developing its lead drug candidate, lumateperone for the treatment of schizophrenia, bipolar disorder, behavioral disturbances associated with dementia, autism, and David Dreman Guru Analysis of Intra-Cellular Therapies Inc ... Unfortunately, we do not have sufficient data available on ITCI at this time. This methodology would utilize four separate criteria to determine if ITCI is a contrarian stock. In order to eliminate weak companies we have stipulated that the stock should pass at least two of the following four major criteria in order to receive "Some Interest".

NewsSee all news. 02 April 2020 Intra-Cellular Therapies Initiates Promotional Activities for CAPLYTA™ (lumateperone) for the Treatment of Schizophrenia in Adults. NEW YORK, April 02, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS)

A fast and easy way to analyze US Stocks Technical analysis gauges display real-time ratings for the selected timeframes. The summary for INTRA-CELLULAR THERAPIES INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots.

ITCI: Intra-Cellular Therapies Inc - Stock Price ... - CNBC

Learn about ITCI with our data and independent analysis including price, star rating, valuation, dividends, and financials. The Year in U.S. Equity Funds, 2019. Intra Cellular Therapies stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. View the latest Intra-Cellular Therapies Inc. (ITCI) stock price, news, historical charts, analyst ratings and financial information from WSJ. View today's stock price, news and analysis for Intra-Cellular Therapies Inc. (ITCI) . Barron's also provides information on historical stock ratings, target prices,  As of 2020 April 07, Tuesday current price of ITCI stock is 15.045$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since  

Why Intra-Cellular Therapies (ITCI) Might Surprise This ...

Mar 19, 2020 · Intra-Cellular Therapies (ITCI) Technical Analysis. When it comes to the technical analysis of ITCI stock, there are more than several important indicators on the company’s success in the market, one of those being the Relative Strength Indicator (RSI), which can show, just as Stochastic measures, what is going on with the value of the stock beneath the data. Intra Cellular Therapies Stock Quote. ITCI - Stock Price ... Intra Cellular Therapies (ITCI) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. The Majority of Analysts Are Still Bullish on Intra ... Mar 12, 2020 · On Wednesday, shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) marked $17.77 per share versus a previous $19.47 closing price. With having a -8.73% loss, an insight into the fundamental values of Intra-Cellular Therapies, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts.

View today's stock price, news and analysis for Intra-Cellular Therapies Inc. (ITCI) . Barron's also provides information on historical stock ratings, target prices,